Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease

Abstract The Alzheimer's disease (AD) scientific field continues to make significant advances in early detection and treatments, which importantly rest on advances in our fundamental understanding of AD pathobiology and its contribution to cognitive decline. Clinical readouts of monoclonal anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Ronald C. Petersen, Ana Graf, Alexandra S. Atkins, Miroslaw Brys, Jennifer Murphy, David S. Miller, Larisa Reyderman, Eric Siemers, Janice Smith, Maria C. Carrillo, Christopher J. Weber
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Online Access:https://doi.org/10.1002/trc2.70069
Tags: Add Tag
No Tags, Be the first to tag this record!